adplus-dvertising
Connect with us

News

Vaccine wastage: What is Canada doing about expiring COVID-19 doses? – Global News

Published

 on


With thousands of COVID-19 vaccine doses set to expire by the end of this month, the federal government and provinces are looking for ways to swiftly get them in people’s arms before they are forced to toss them out.

As of April 14, more than 14 million doses were sitting in the central vaccine inventory, according to the Public Health Agency of Canada (PHAC).

Among those, 429,450 doses of the Moderna vaccine will expire by the end of April, PHAC told Global News in an email on Tuesday.

Already, some 759,948 expired Moderna doses were wasted last month after expiring on March 21.

Read more:

COVID-19 vaccines in Canada’s stockpile starting to expire as uptake slows

To minimize more wastage, the federal agency says it has a few options on its hands, including transferring doses between jurisdictions, donating vaccines and reviewing for any pending shelf life extensions.

Health Canada has revised expiration dates multiple times in the last year, as the companies that make the vaccines were able to get better data on how long the vaccines remained viable.

Pfizer’s shelf life was extended from six months to nine months last summer, and Moderna’s from seven months to nine months in December.

“If the shelf life of the doses cannot be extended, they will be disposed of appropriately,” PHAC said.

Managing vaccines

Provinces say vaccine wastage has been minimal so far, but with a slower uptake of booster shots amid a sixth wave, experts are concerned that not enough is being done to get the available doses into Canadian arms.

“We are allowing them to expire without even making an effort to move them forward and we’re not being transparent about it,” said Kerry Bowman, a professor of bioethics and global health at the University of Toronto.

“We need to make a clear decision as to what we need now and we need a management plan, which we have not seen,” he told Global News.

Read more:

Canada looking to fill global vaccine gap as COVAX runs short on funds

Donations are one option to manage the supply Canadians are not using.

As part of the WHO-led COVAX vaccine sharing facility, Canada has pledged to donate 38 million doses from its own domestic supplies, and another 13 million from doses Canada bought for itself from COVAX but didn’t need.

So far, Canada has only donated 15 million, but demand has fallen this year as supplies to the COVAX pool exceeded the ability of countries to get doses into arms.


Click to play video: 'WHO technical lead says countries need ability to purchase COVID-19 vaccines'



1:06
WHO technical lead says countries need ability to purchase COVID-19 vaccines


WHO technical lead says countries need ability to purchase COVID-19 vaccines – Dec 5, 2021

Bowman criticized Canada for falling short on its promises to help low-income countries, saying it “has not been a priority for Canada”.

While wastage in any vaccination campaign is not uncommon as more doses are ordered than needed, the waste during the COVID-19 pandemic has been “a bit higher than normal,” said Dr. Dasantila Golemi-Kotra, an associate professor of microbiology at York University.

She blamed government miscalculation, problematic public health messaging, COVID-19 misinformation and vaccine hesitancy for the low uptake that is resulting in doses left unused.

“There is a need and the efforts have to be made to tell the public that we are not done with the virus.”


Click to play video: 'Thousands of Moderna COVID-19 vaccine doses risk expiring, going to waste'



2:01
Thousands of Moderna COVID-19 vaccine doses risk expiring, going to waste


Thousands of Moderna COVID-19 vaccine doses risk expiring, going to waste – Aug 2, 2021

Where do provinces stand?

Global News reached out to all 10 provinces and three territories and asked about their current vaccine stockpile, how many doses have been wasted and how they were planning to manage the supply.

Here is what they had to say.

Quebec currently has approximately 3.8 million doses of different COVID-19 vaccines. Some 120,000 doses will expire in May, and another 672,000 in June, a spokesperson for Quebec’s Ministry of Health and Social Services (MSSS) told Global News.

By the end of March 2022, 107,501 doses, of mostly Moderna, were destroyed as they had passed the expiration date, Robert Maranda, MSSS spokesperson, said.

Manitoba has roughly 320,000 COVID-19 doses in stock at its provincial warehouse, which are due to expire in May through August 2022, a provincial spokesperson said.

Since the start of Manitoba’s COVID-19 immunization program, wastage has been limited to two per cent.

“Immunization providers in Manitoba order only enough COVID-19 vaccines to meet current demands,” the spokesperson told Global News in an email.

The province began contributing vaccines for redistribution in late July 2021, said a spokesperson for Manitoba’s Labour, Consumer Protection and Government Services Minister Reg Helwer.

As of early March, more than 182,000 doses had been provided by Manitoba for federal redistribution.

In Saskatchewan, as of April 18, there were approximately 300,000 doses in the provincial inventory, with expiry dates ranging between April 30, 2022 to September 30, 2023.

To date, 2.4 per cent or 71,000 doses of COVID-19 vaccine have been wasted due to expiry out of 3,002,735 total doses received in the province, Saskatchewan’s Ministry of Health said.

“The province anticipates minimal wastage from the current inventory potentially due to vaccine exceeding storage time allowances for refrigerated conditions and punctured vials, as well as exceeding the product expiry date,” the ministry told Global News in an email.

To mitigate vaccine wastage, Saskatchewan has been redistributing doses within the province, offering to other jurisdictions or releasing back to the federal government, the ministry said.


Click to play video: '4th COVID-19 vaccine doses in high demand now that eligibility has expanded'



2:01
4th COVID-19 vaccine doses in high demand now that eligibility has expanded


4th COVID-19 vaccine doses in high demand now that eligibility has expanded – Apr 7, 2022

As for Prince Edward Island, there are currently 37,000 doses of mRNA vaccines, which will expire in late 2022, and mid-2023.

The province anticipates that less than 100 doses of vaccine will expire later this month, according to Dr. Heather Morrison, P.E.I’s chief public health officer.

“We will be exploring options in neighboring provinces to reallocate expiring doses to see if they can be used before their expiry date,” she told Global News.

“Some wastage is difficult to avoid given the demand for some vaccines is very low (e.g., AstraZeneca and Janssen),” Morrison said, adding that the province aims to keep wastage to a minimum.

“In the coming months, we do not foresee any other vaccine wastage, due to product expiry.”


Click to play video: 'Approximately 10% of COVID-19 vaccines wasted or expired: Alberta Health'



2:02
Approximately 10% of COVID-19 vaccines wasted or expired: Alberta Health


Approximately 10% of COVID-19 vaccines wasted or expired: Alberta Health – Nov 17, 2021

In Alberta, to date, approximately 13 per cent of the doses that the province has received from the federal government have been wasted or expired.

“Some wastage is inevitable with the current COVID vaccines, as unused doses from multi-use vials must be discarded after 12 hours, and we are supplying more than 1,000 locations across the province in order to maximize access and help get more Albertans vaccinated,” Alberta Health told Global News.

“A large number of locations serving relatively small numbers of patients each day per site means more wastage,” the emailed statement added.

Canada’s most populous province, Ontario, did not provide any data about its current vaccine supply and wasted doses.

In an emailed response to Global News, Bill Campbell, a spokesperson for Ontario’s Ministry of Health said: “We continue to monitor and ensure vaccines are focused in areas of need while also working with our federal partners to explore opportunities to donate additional vaccine doses.”

Vaccine data transparency

Despite multiple requests, Global News did not get a response from British Columbia, Nova Scotia, Newfoundland and Labrador and New Brunswick by the time of publication.

Experts say there should be greater transparency when it comes to disclosing vaccine information.

Both Bowman and Golemi-Kotra suspect the secrecy with wastage numbers stems from provinces not wanting to look bad.

“It doesn’t reflect well on the provinces that so much of these vaccines were acquired, and yet many were left unused,” said Golemi-Kotra.


Click to play video: 'Ontario won’t say how many AstraZeneca COVID-19 vaccine are at risk of expiring'



2:27
Ontario won’t say how many AstraZeneca COVID-19 vaccine are at risk of expiring


Ontario won’t say how many AstraZeneca COVID-19 vaccine are at risk of expiring – May 28, 2021

Bowman said Canadians have a right to know how much the government paid for the vaccines and what the disposed doses are going to cost.

He believes disclosing this information could in fact help bolster the vaccinations campaign and increase uptake.

— with files from The Canadian Press

© 2022 Global News, a division of Corus Entertainment Inc.

Adblock test (Why?)

728x90x4

Source link

Continue Reading

News

STD epidemic slows as new syphilis and gonorrhea cases fall in US

Published

 on

 

NEW YORK (AP) — The U.S. syphilis epidemic slowed dramatically last year, gonorrhea cases fell and chlamydia cases remained below prepandemic levels, according to federal data released Tuesday.

The numbers represented some good news about sexually transmitted diseases, which experienced some alarming increases in past years due to declining condom use, inadequate sex education, and reduced testing and treatment when the COVID-19 pandemic hit.

Last year, cases of the most infectious stages of syphilis fell 10% from the year before — the first substantial decline in more than two decades. Gonorrhea cases dropped 7%, marking a second straight year of decline and bringing the number below what it was in 2019.

“I’m encouraged, and it’s been a long time since I felt that way” about the nation’s epidemic of sexually transmitted infections, said the CDC’s Dr. Jonathan Mermin. “Something is working.”

More than 2.4 million cases of syphilis, gonorrhea and chlamydia were diagnosed and reported last year — 1.6 million cases of chlamydia, 600,000 of gonorrhea, and more than 209,000 of syphilis.

Syphilis is a particular concern. For centuries, it was a common but feared infection that could deform the body and end in death. New cases plummeted in the U.S. starting in the 1940s when infection-fighting antibiotics became widely available, and they trended down for a half century after that. By 2002, however, cases began rising again, with men who have sex with other men being disproportionately affected.

The new report found cases of syphilis in their early, most infectious stages dropped 13% among gay and bisexual men. It was the first such drop since the agency began reporting data for that group in the mid-2000s.

However, there was a 12% increase in the rate of cases of unknown- or later-stage syphilis — a reflection of people infected years ago.

Cases of syphilis in newborns, passed on from infected mothers, also rose. There were nearly 4,000 cases, including 279 stillbirths and infant deaths.

“This means pregnant women are not being tested often enough,” said Dr. Jeffrey Klausner, a professor of medicine at the University of Southern California.

What caused some of the STD trends to improve? Several experts say one contributor is the growing use of an antibiotic as a “morning-after pill.” Studies have shown that taking doxycycline within 72 hours of unprotected sex cuts the risk of developing syphilis, gonorrhea and chlamydia.

In June, the CDC started recommending doxycycline as a morning-after pill, specifically for gay and bisexual men and transgender women who recently had an STD diagnosis. But health departments and organizations in some cities had been giving the pills to people for a couple years.

Some experts believe that the 2022 mpox outbreak — which mainly hit gay and bisexual men — may have had a lingering effect on sexual behavior in 2023, or at least on people’s willingness to get tested when strange sores appeared.

Another factor may have been an increase in the number of health workers testing people for infections, doing contact tracing and connecting people to treatment. Congress gave $1.2 billion to expand the workforce over five years, including $600 million to states, cities and territories that get STD prevention funding from CDC.

Last year had the “most activity with that funding throughout the U.S.,” said David Harvey, executive director of the National Coalition of STD Directors.

However, Congress ended the funds early as a part of last year’s debt ceiling deal, cutting off $400 million. Some people already have lost their jobs, said a spokeswoman for Harvey’s organization.

Still, Harvey said he had reasons for optimism, including the growing use of doxycycline and a push for at-home STD test kits.

Also, there are reasons to think the next presidential administration could get behind STD prevention. In 2019, then-President Donald Trump announced a campaign to “eliminate” the U.S. HIV epidemic by 2030. (Federal health officials later clarified that the actual goal was a huge reduction in new infections — fewer than 3,000 a year.)

There were nearly 32,000 new HIV infections in 2022, the CDC estimates. But a boost in public health funding for HIV could also also help bring down other sexually transmitted infections, experts said.

“When the government puts in resources, puts in money, we see declines in STDs,” Klausner said.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

Source link

Continue Reading

News

World’s largest active volcano Mauna Loa showed telltale warning signs before erupting in 2022

Published

 on

 

WASHINGTON (AP) — Scientists can’t know precisely when a volcano is about to erupt, but they can sometimes pick up telltale signs.

That happened two years ago with the world’s largest active volcano. About two months before Mauna Loa spewed rivers of glowing orange molten lava, geologists detected small earthquakes nearby and other signs, and they warned residents on Hawaii‘s Big Island.

Now a study of the volcano’s lava confirms their timeline for when the molten rock below was on the move.

“Volcanoes are tricky because we don’t get to watch directly what’s happening inside – we have to look for other signs,” said Erik Klemetti Gonzalez, a volcano expert at Denison University, who was not involved in the study.

Upswelling ground and increased earthquake activity near the volcano resulted from magma rising from lower levels of Earth’s crust to fill chambers beneath the volcano, said Kendra Lynn, a research geologist at the Hawaiian Volcano Observatory and co-author of a new study in Nature Communications.

When pressure was high enough, the magma broke through brittle surface rock and became lava – and the eruption began in late November 2022. Later, researchers collected samples of volcanic rock for analysis.

The chemical makeup of certain crystals within the lava indicated that around 70 days before the eruption, large quantities of molten rock had moved from around 1.9 miles (3 kilometers) to 3 miles (5 kilometers) under the summit to a mile (2 kilometers) or less beneath, the study found. This matched the timeline the geologists had observed with other signs.

The last time Mauna Loa erupted was in 1984. Most of the U.S. volcanoes that scientists consider to be active are found in Hawaii, Alaska and the West Coast.

Worldwide, around 585 volcanoes are considered active.

Scientists can’t predict eruptions, but they can make a “forecast,” said Ben Andrews, who heads the global volcano program at the Smithsonian Institution and who was not involved in the study.

Andrews compared volcano forecasts to weather forecasts – informed “probabilities” that an event will occur. And better data about the past behavior of specific volcanos can help researchers finetune forecasts of future activity, experts say.

(asterisk)We can look for similar patterns in the future and expect that there’s a higher probability of conditions for an eruption happening,” said Klemetti Gonzalez.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

The Canadian Press. All rights reserved.

Source link

Continue Reading

News

Waymo’s robotaxis now open to anyone who wants a driverless ride in Los Angeles

Published

 on

 

Waymo on Tuesday opened its robotaxi service to anyone who wants a ride around Los Angeles, marking another milestone in the evolution of self-driving car technology since the company began as a secret project at Google 15 years ago.

The expansion comes eight months after Waymo began offering rides in Los Angeles to a limited group of passengers chosen from a waiting list that had ballooned to more than 300,000 people. Now, anyone with the Waymo One smartphone app will be able to request a ride around an 80-square-mile (129-square-kilometer) territory spanning the second largest U.S. city.

After Waymo received approval from California regulators to charge for rides 15 months ago, the company initially chose to launch its operations in San Francisco before offering a limited service in Los Angeles.

Before deciding to compete against conventional ride-hailing pioneers Uber and Lyft in California, Waymo unleashed its robotaxis in Phoenix in 2020 and has been steadily extending the reach of its service in that Arizona city ever since.

Driverless rides are proving to be more than just a novelty. Waymo says it now transports more than 50,000 weekly passengers in its robotaxis, a volume of business numbers that helped the company recently raise $5.6 billion from its corporate parent Alphabet and a list of other investors that included venture capital firm Andreesen Horowitz and financial management firm T. Rowe Price.

“Our service has matured quickly and our riders are embracing the many benefits of fully autonomous driving,” Waymo co-CEO Tekedra Mawakana said in a blog post.

Despite its inroads, Waymo is still believed to be losing money. Although Alphabet doesn’t disclose Waymo’s financial results, the robotaxi is a major part of an “Other Bets” division that had suffered an operating loss of $3.3 billion through the first nine months of this year, down from a setback of $4.2 billion at the same time last year.

But Waymo has come a long way since Google began working on self-driving cars in 2009 as part of project “Chauffeur.” Since its 2016 spinoff from Google, Waymo has established itself as the clear leader in a robotaxi industry that’s getting more congested.

Electric auto pioneer Tesla is aiming to launch a rival “Cybercab” service by 2026, although its CEO Elon Musk said he hopes the company can get the required regulatory clearances to operate in Texas and California by next year.

Tesla’s projected timeline for competing against Waymo has been met with skepticism because Musk has made unfulfilled promises about the company’s self-driving car technology for nearly a decade.

Meanwhile, Waymo’s robotaxis have driven more than 20 million fully autonomous miles and provided more than 2 million rides to passengers without encountering a serious accident that resulted in its operations being sidelined.

That safety record is a stark contrast to one of its early rivals, Cruise, a robotaxi service owned by General Motors. Cruise’s California license was suspended last year after one of its driverless cars in San Francisco dragged a jaywalking pedestrian who had been struck by a different car driven by a human.

Cruise is now trying to rebound by joining forces with Uber to make some of its services available next year in U.S. cities that still haven’t been announced. But Waymo also has forged a similar alliance with Uber to dispatch its robotaxi in Atlanta and Austin, Texas next year.

Another robotaxi service, Amazon’s Zoox, is hoping to begin offering driverless rides to the general public in Las Vegas at some point next year before also launching in San Francisco.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending